Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Proteomic analysis of plasma identifies the Toll-like receptor agonists S100A8/A9 as a novel possible marker for systemic sclerosis phenotype.

Annals of the rheumatic diseases - 1 Aug 2014

van Bon L, Cossu M, Loof A, Gohar F, Wittkowski H, Vonk M, Roth J, van den Berg W, van Heerde W, Broen J C A, Radstake T R D J

Abstract excerpt

BACKGROUND: Systemic sclerosis (SSc) is an autoimmune disease characterised by fibrosis of the skin and the internal organs. Except for anticentromere, antitopoisomerase I and antipolymerase III antibodies, there are no reliable circulating markers predicting susceptibility and internal organ complications. This study has exploited a proteome-wide profiling method with the aim to identify new markers to identify...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenotype

Share to Proteomics

Share to Pulmonary Fibrosis

Share to Scleroderma, Systemic

Share to Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

Share to Toll-Like Receptors

Source

Identifiers

PMID: 24718960
DOI: 10.1136/annrheumdis-2013-205013

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Proteomic analysis of plasma identifies the Toll-like receptor agonists S100A8/A9 as a novel possible marker for systemic sclerosis phenotype.PMID 24718960Read ↗

Proteomic Biomarkers for Survival in Systemic Sclerosis-associated Pulmonary HypertensionSemantic proximity Read ↗

Proteomic aptamer analysis reveals serum biomarkers associated with disease mechanisms and phenotypes of systemic sclerosis.Semantic proximity Read ↗

The Evolving Landscape of Systemic Sclerosis Pathogenesis: From Foundational Mechanisms to Organ-Specific ModifiersSemantic proximity Read ↗

Clinical and pathogenic significance of S100A4 overexpression in systemic sclerosis.Semantic proximity Read ↗

Deciphering Systemic Sclerosis Phenotypes: A Novel Approach Using Clustering Algorithms and Proteomic Insights. Results from the PRECISESADS Study.Semantic proximity Read ↗

A review of recent studies on the pathogenesis of Systemic Sclerosis: focus on fibrosis pathwaysSemantic proximity Read ↗

Emerging Blood Biomarkers in Systemic Sclerosis: From Single Molecules to Biomarker-Based Patient StratificationSemantic proximity Read ↗

Epidemiology of systemic sclerosis.Semantic proximity Read ↗

Mapping the plasma proteomic architecture of systemic lupus erythematosusSemantic proximity Read ↗

Novel insights on the role of the innate immune system in systemic sclerosis.Semantic proximity Read ↗

Proteomic analysis of scleroderma lesional skin reveals activated wound healing phenotype of epidermal cell layer.Semantic proximity Read ↗

Identification of lncRNA–miRNA–mRNA networks in circulating exosomes as potential biomarkers for systemic sclerosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.